Health
Pfizer begins vaccine trial on children aged 11 and younger – The Times of Israel
Three different dosing levels are being tested; company is already testing the shots on kids aged 12-15
WASHINGTON — Pfizer said Thursday it had begun clinical trials for its Covid vaccine in children under the age of eleven, an early sign of the next stage of the global immunization campaign.
“Together with our partner BioNTech, we have dosed the first healthy children in a global Phase 1/2/3 continuous study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine,” the company said in a statement to AFP.
“We are proud to start this much needed study…
-
Business19 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business10 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business12 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.